New Delhi, June 22 (Xinhua) - Katemera wa India Bharat Biotech's Covaxin's Covaxin ya Biotech III III mayesero, media angapo akutchulidwa Lachiwiri.
"Bharat Biotech's Cootech's Cooxin ndi 77.8 peresenti yothandiza poteteza Covid-19, malinga ndi deta kuchokera ku mayesero a Puse III yomwe achitika pa 25,800 ophunzira," lipoti linatero.
Manambala olimbitsa thupi adatuluka Lachiwiri pambuyo pa mankhwala owongolera mankhwala a India (DCGI)
Wogwiritsa ntchito mankhwala anali atapereka deta yoyeserera ya Phase III pa katemera wa DCGI kumapeto kwa sabata.
Malipoti anena kuti kampaniyo ikuyembekezeka kukhala ndi msonkhano wa World Organisation Atsogoleri Organisation Lachitatu Lachitatu, kukambirana malangizo a kutumiza komaliza.
India adayamba katemera wambiri ku Covid-19 pa Jan. 16 popereka katemera awiri ku India, ndi Covirishield ndi Covaxin.
Serum Institute of India (SII) ikupanga Covipield ya Astrawnca-OxFord pomwe adagawana ndi bungwe la India la kafukufuku waku India (ICMR) pakupanga covaxin.
Katemera wopangidwa ndi Russian v ratnik adakulungidwanso mdzikolo. Embute
Post Nthawi: Jun-25-2021